Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
38.55 INR | +0.65% | +5.56% | +44.38% |
May. 18 | Transchem Limited Reports Earnings Results for the Full Year Ended March 31, 2024 | CI |
May. 18 | Transchem Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024 | CI |
Valuation
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 397.8 | 290.7 | 198.9 | 204.4 | 269.3 | 231.5 |
Enterprise Value (EV) 1 | 310.4 | 124.3 | 34.33 | 86.62 | -74.43 | -113.5 |
P/E ratio | -33.4 x | 95.3 x | 48.6 x | 0.85 x | 9.39 x | 18.7 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | - | - | - | - | - | - |
EV / Revenue | - | - | - | - | - | - |
EV / EBITDA | -18.3 x | -11.3 x | -2.46 x | -4.48 x | 4.77 x | 7.26 x |
EV / FCF | -1.5 x | 1.37 x | -1.38 x | -0.28 x | -0.41 x | 10.9 x |
FCF Yield | -66.8% | 72.8% | -72.3% | -355% | -247% | 9.15% |
Price to Book | 1.08 x | 0.77 x | 0.54 x | 0.32 x | 0.41 x | 0.35 x |
Nbr of stocks (in thousands) | 12,240 | 12,240 | 12,240 | 12,240 | 12,240 | 12,240 |
Reference price 2 | 32.50 | 23.75 | 16.25 | 16.70 | 22.00 | 18.91 |
Announcement Date | 8/29/18 | 8/9/19 | 7/7/20 | 9/3/21 | 6/7/22 | 7/6/23 |
Income Statement Evolution (Annual data)
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales | - | - | - | - | - | - |
EBITDA 1 | -16.92 | -11.03 | -13.93 | -19.35 | -15.62 | -15.63 |
EBIT 1 | -26.61 | -19.01 | -19.67 | -20.59 | -15.7 | -15.71 |
Operating Margin | - | - | - | - | - | - |
Earnings before Tax (EBT) 1 | -5.499 | 7.75 | 7.926 | 247.7 | 39.08 | 25.04 |
Net income 1 | -11.9 | 3.05 | 4.096 | 241.5 | 28.68 | 12.37 |
Net margin | - | - | - | - | - | - |
EPS 2 | -0.9719 | 0.2492 | 0.3346 | 19.73 | 2.343 | 1.011 |
Free Cash Flow 1 | -207.2 | 90.47 | -24.83 | -307.1 | 183.7 | -10.39 |
FCF margin | - | - | - | - | - | - |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | - | 2,965.98% | - | - | 640.49% | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 8/29/18 | 8/9/19 | 7/7/20 | 9/3/21 | 6/7/22 | 7/6/23 |
Balance Sheet Analysis
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - | - |
Net Cash position 1 | 87.4 | 166 | 165 | 118 | 344 | 345 |
Leverage (Debt/EBITDA) | - | - | - | - | - | - |
Free Cash Flow 1 | -207 | 90.5 | -24.8 | -307 | 184 | -10.4 |
ROE (net income / shareholders' equity) | -3.18% | 0.82% | 1.1% | 48.4% | 4.44% | 1.87% |
ROA (Net income/ Total Assets) | -4.43% | -3.15% | -3.26% | -2.56% | -1.51% | -1.48% |
Assets 1 | 268.7 | -96.7 | -125.7 | -9,429 | -1,904 | -838.4 |
Book Value Per Share 2 | 30.10 | 31.00 | 30.00 | 51.40 | 54.20 | 53.80 |
Cash Flow per Share 2 | 0.2200 | 13.30 | 13.40 | 9.570 | 28.00 | 28.20 |
Capex | - | 0.04 | - | 0.82 | - | - |
Capex / Sales | - | - | - | - | - | - |
Announcement Date | 8/29/18 | 8/9/19 | 7/7/20 | 9/3/21 | 6/7/22 | 7/6/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+44.38% | 5.65M | |
+111.71% | 6.55B | |
+98.02% | 1.23B | |
+2.52% | 986M | |
+14.96% | 752M | |
+2.11% | 666M | |
+2.33% | 620M | |
-.--% | 600M | |
+8.61% | 528M | |
-.--% | 500M |
- Stock Market
- Equities
- TRANSCHEM Stock
- Financials Transchem Limited